Fucosidosis: Clinical Trials

10 trials for Fucosidosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 terminated, 1 active not recruiting, 1 recruiting. 5 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Active not recruiting 1, Terminated 1
Phase 12Completed 2
Phase 32Completed 1, Terminated 1

Follow Fucosidosis: new trials by email Literature Review of Fucosidosis trials Research Report on Fucosidosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Long-Term Observational Study of Patients With Fucosidosis
Fucosidosis
RecruitingJCR Pharmaceuticals Co., Ltd.572026-03-252026-09-17
MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
Stem Cell Transplantation, IMD Preparative Regimen, Osteopetrosis Only Preparative Regimen - Mucopolysaccharidosis Disorders, Hurler Syndrome
Phase 2Active not recruitingMasonic Cancer Center, University of Minnesota1492014-07-102026-01-07
Human Placental-Derived Stem Cell Transplantation
Human Placental Derived Stem Cell - Mucopolysaccharidosis I, Mucopolysaccharidosis VI
Phase 1CompletedNew York Medical College432013-04-012022-10-25
Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
Campath-1H, Cyclophosphamide, Busulfan - Mucopolysaccharidosis, Hurler Syndrome
Phase 2CompletedMasonic Cancer Center, University of Minnesota462009-12-012018-02-05
Longitudinal Studies of the Glycoproteinoses
Non-interventional. - Aspartylglucosaminuria, Fucosidosis
CompletedGreenwood Genetic Center1002009-08-012023-09-13
Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells
Hematopoietic stem cell transplantation - Sickle Cell Disease, Thalassemia
Phase 1 / Phase 2CompletedChildren's Hospital Los Angeles252008-08-012016-06-23
Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
Stem Cell Transplantation, Cyclophosphamide, Campath-1H - Hurler's Syndrome, Maroteaux-Lamy Syndrome
Phase 2TerminatedMasonic Cancer Center, University of Minnesota182008-03-012017-12-28
ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases
ALD-101 - Inherited Metabolic Diseases, Lysosomal Storage Disorders
Phase 3TerminatedAldagen402008-03-012014-07-08
Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
I Cell Disease, Fucosidosis
UnknownFairview University Medical Center101999-08-012005-06-24
Stem Cell Transplant for Inborn Errors of Metabolism
Stem Cell Transplant, Busulfan, Cyclophosphamide, Antithymocyte Globulin - Adrenoleukodystrophy, Metachromatic Leukodystrophy
Phase 2 / Phase 3CompletedMasonic Cancer Center, University of Minnesota1351995-01-012017-12-28

Narrower conditions

Leukodystrophy, Globoid Cell (7)  ·  Leukodystrophy, Metachromatic (7)  ·  Mucopolysaccharidosis I (7)  ·  Mucopolysaccharidosis VI (6)  ·  Adrenoleukodystrophy (5)  ·  Metabolism, Inborn Errors (5)  ·  alpha-Mannosidosis (5)  ·  Aspartylglucosaminuria (4)  ·  Niemann-Pick Diseases (4)  ·  Sphingolipidoses (4)  ·  Wolman Disease (4)  ·  Gaucher Disease (3)  ·  Genetic Diseases, Inborn (3)  ·  Lysosomal Storage Diseases (3)

Broader conditions

Brain Diseases (10)  ·  Brain Diseases, Metabolic (10)  ·  Central Nervous System Diseases (10)  ·  Nervous System Diseases (10)  ·  Nutritional and Metabolic Diseases (10)  ·  Brain Diseases, Metabolic, Inborn (9)  ·  Carbohydrate Metabolism, Inborn Errors (9)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9)  ·  Lysosomal Storage Diseases, Nervous System (9)  ·  Metabolic Diseases (9)  ·  Lipid Metabolism Disorders (8)  ·  Lipid Metabolism, Inborn Errors (8)  ·  Lipidoses (8)  ·  Connective Tissue Diseases (7)  ·  Demyelinating Diseases (7)

Interventions

Stem Cell Transplantation (4)  ·  Busulfan (3)  ·  Cyclophosphamide (3)  ·  Alemtuzumab (2)  ·  Bone Marrow Transplantation (2)  ·  Antilymphocyte Serum (1)  ·  Cyclosporine (1)  ·  Hematopoietic Stem Cell Transplantation (1)  ·  Mycophenolic Acid (1)  ·  Regimen B (1)

Sponsors

Masonic Cancer Center, University of Minnesota (4)  ·  Aldagen (1)  ·  Children's Hospital Los Angeles (1)  ·  Fairview University Medical Center (1)  ·  Greenwood Genetic Center (1)  ·  JCR Pharmaceuticals Co., Ltd. (1)  ·  New York Medical College (1)

Countries

United States (10)  ·  India (1)  ·  Netherlands (1)  ·  Tunisia (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Paul Orchard, MD (3)  ·  Hisham Abdel-Azim, MD (1)  ·  James Hinson, MD (1)  ·  Joanne Kurtzberg, MD (1)  ·  K. Scott Baker (1)  ·  Karolina M Stepien, MD (1)  ·  Mitchell S Cairo, MD (1)  ·  Paul Orchard, M.D. (1)  ·  Sara Cathey, MD (1)

Results publications

PMID 21586746, PMID 19617216